The lineage-determining transcription factor CCAAT enhancer binding protein ␣ (C͞EBP␣) is required for myeloid differentiation. Decreased function or expression of C͞EBP␣ is often found in human acute myeloid leukemia. However, the precise impact of C͞EBP␣ deficiency on the maturation arrest in leukemogenesis is not well understood. To address this question, we used a murine transplantation model of a bcr͞abl-induced myeloproliferative disease. The expression of bcr͞abl in C͞EBP␣ pos fetal liver cells led to a chronic myeloid leukemia-like disease. Surprisingly, bcr͞abl-expressing C͞EBP␣ ؊/؊ fetal liver cells failed to induce a myeloid disease in transplanted mice, but caused a fatal, transplantable erythroleukemia instead. Accordingly, increased expression of the transcription factors SCL and GATA-1 in hematopoietic precursor cells of C͞EBP␣ ؊/؊ fetal livers was found. The mechanism for the lineage shift from myeloid to erythroid leukemia was studied in a bcr͞abl-positive cell line. Consistent with findings of the transplant model, expression of C͞EBP␣ and GATA-1 was inversely correlated. Id1, an inhibitor of erythroid differentiation, was identified as a critical direct target of C͞EBP␣. Down-regulation of Id1 by RNA interference impaired C͞EBP␣-induced granulocytic differentiation. Taken together, our study provides evidence that myeloid lineage identity of malignant hematopoietic progenitor cells requires the residual expression of C͞EBP␣.
differentiation ͉ leukemia ͉ lineage commitment C urrent concepts for leukemogenesis suggest that at least two genetic events are necessary for the development of acute myeloid leukemia (AML). Some are required to interrupt normal myeloid differentiation and frequently involve transcription factors. Others confer a proliferative or antiapoptotic signal. However, although several loss-of-function mutations of transcription factors have been described in AML (1), little is known about the precise role of transcription factor deficiency in leukemogenesis. To further address this issue, we combined the deficiency of a transcription factor required for myeloid differentiation with the expression of an activated tyrosine kinase in a murine transplantation model.
As the target transcription factor, CCAAT enhancer binding protein ␣ (C͞EBP␣) was chosen. C͞EBP␣ is essential for normal differentiation of myeloid progenitors. C͞EBP␣-deficient mice demonstrate a lack of mature granulocytes (2) . Analysis of hematopoietic precursors of C͞EBP␣-deleted mice showed that granulopoiesis is blocked at the transition from the common myeloid progenitor (CMP) to the granulocyte macrophage precursor (GMP) (3) . The lack of mature granulocytes together with the accumulation of immature cells in the bone marrow (BM) is reminiscent of AML. Accordingly, dominant negative mutations in the C͞EBP␣ gene have been described in human AML (4). Moreover, it has been shown that AML1͞ETO, the fusion protein resulting from the t (8, 21) translocation, leads to down-regulation of C͞EBP␣ RNA levels (5) .
As a proliferative and͞or antiapoptotic signal, bcr͞abl was selected. Bcr͞abl is a constitutively activated tyrosine kinase resulting from the t (9, 22) chromosomal translocation in chronic myelogenous leukemia (CML). In human CML, bcr͞abl causes a chronic phase characterized by an increased production of granulocytic cells with normal maturation. Retroviral expression of bcr͞abl in mouse BM transplantation assays leads to increased proliferation of myeloid progenitors and accumulation of mature myeloid cells, resembling the chronic phase of human disease (reviewed in ref. 6 ). In most cases of human CML, the disease ultimately undergoes a transition to blast crisis. The majority of blast crises have a myeloid (65%) or lymphoid (30%) phenotype, but erythroid blast crisis has also been described (7) . This transformation occurs mostly after several years and has been attributed to secondary genetic events (6) . In myeloid blast crisis, granulocytic differentiation is blocked, and BM and blood demonstrate immature myeloid blasts similar to those observed in AML. Down-regulation of C͞EBP␣ protein has been implicated in this transition (8) .
In this study, we asked whether C͞EBP␣ deficiency in the context of bcr͞abl-induced murine leukemia would promote the differentiation block observed in human AML. We show that in the absence of C͞EBP␣ bcr͞abl induces an immature erythroleukemia, and no myeloid cells are detected. These results indicate that in malignant hematopoiesis residual C͞EBP␣ function is also required for myeloid lineage commitment. Fig. 1A1 ). In mice transplanted with bcr͞abl-expressing C͞EBP␣ Ϫ/Ϫ cells the blood smears showed erythroid precursor elements (Fig. 1 A2) . These normoblasts and erythroblasts comprised two-thirds of the nucleated cells, and a significant number of proerythroblasts were detected. The lymphocytic and granulocytic compartments were reduced (Table 1) .
Results

Mice Transplanted with bcr͞abl-Expressing C͞EBP␣
In BM and spleen the same phenotype of the malignant cells was detected (Table 2 , which is published as supporting information on the PNAS web site). Bcr͞abl protein was demonstrated in the leukemic cells (Fig. 1B) . Cytologic and histologic analysis of mice transplanted with bcr͞abl-expressing C͞EBP␣ pos cells displayed a cellular composition consistent with chronic-phase CML. An accumulation of mature granulocytes, variably increased numbers of late nucleated erythroid precursors, and a reduction in lymphocytes were detected ( Fig. 1 C1  and D1 ). The preponderance of cells stained positive for myeloperoxidase (MPO) (Fig. 1D2) . In contrast, an accumulation of immature erythroid cells was observed after transplantation with bcr͞abl-expressing C͞EBP␣ Ϫ/Ϫ cells ( Fig. 1 C2, D3 , and D4). MPO-positive cells were markedly reduced (Fig. 1D5) . In More than 80% of the mice were killed within 60 days after transplantation. The mouse with acute lymphocytic leukemia (recipient of C͞EBP␣ ϩ͞Ϫ ϩ bcr͞abl) is not included. For the differential counts, the percentage of each type of the nucleated blood cells Ϯ SD is given. *n ϭ 7 for C͞EBP␣ pos and n ϭ 9 for C͞EBP␣ Ϫ͞Ϫ transplants.
† n ϭ 4 for C͞EBP␣ pos and n ϭ 5 for C͞EBP␣ Ϫ͞Ϫ transplants. ‡ Myelocytes include promyelocytes, myelocytes, and metamyelocytes. § P Ͻ 0.05. addition to the expansion of erythroblasts, an increase of mast cells, confirmed by immunohistochemistry for mast cell tryptase and touloudine blue staining, was found in some of the mice ( Fig.  1 C3 and D6) . Flow cytometry supported the histologic and cytologic observations. Whereas a predominance of Gr-1 ϩ ͞ Mac1 ϩ cells was detected after transplantation with bcr͞abl-expressing C͞EBP␣ pos cells (data not shown), an increase in expression of the erythroid marker TER-119 and c-kit, a marker for hematopoietic progenitors, was observed after transplantation with bcr͞abl-expressing C͞EBP␣ Ϫ/Ϫ cells (Fig. 1E) . Erythroid maturation is accompanied by a decrease of CD71 surface expression in TER-119-positive cells (9) . The majority of erythroblasts after transplantation with bcr͞abl-expressing C͞EBP␣ Ϫ/Ϫ cells exhibited high expression of CD71 (Fig. 1E) , indicating the presence of immature erythropoiesis. In contrast, in control mice lower CD71 expression was observed (data not shown). In summary, mice transplanted with bcr͞abl-expressing C͞EBP␣ pos fetal liver cells displayed CML as described after transduction and transplantation of BM cells. One recipient mouse developed a B-lineage acute lymphoblastic leukemia (data not shown). However, mice transplanted with bcr͞abl-expressing C͞EBP␣ Ϫ/Ϫ cells demonstrated a complete absence of cells with myeloid identity.
Myeloid Differentiation Capacity Is Absent in C͞EBP␣ ؊/؊ Leukemic
Repopulating Cells. Histologic analysis of extrahematopoietic tissues supported a malignant phenotype of the bcr͞abl-expressing cells. In mice transplanted with C͞EBP␣ pos cells, prominent granulocytic infiltrates and extramedullary hematopoiesis, including maturing erythroid elements and megakaryocytes, were observed in the liver (Fig. 6A , which is published as supporting information on the PNAS web site). In mice transplanted with C͞EBP␣ Ϫ/Ϫ cells, extramedullary erythropoiesis was also appreciated. However, in contrast to the wild-type cells, C͞EBP␣ Ϫ/Ϫ cells showed increased immature forms with a blast-like appearance and large nuclei consistent with erythroblasts (Fig. 6B) .
To assess the differentiation capacity of the leukemic stem cell, bcr͞abl-expressing C͞EBP␣ Ϫ/Ϫ cells from a moribund animal were transplanted into secondary recipients. Five of six mice died of malignant hematologic disease with a latency of 110-215 days. Infiltrates of malignant erythropoiesis and/or mast cells led to suppression of normal hematopoiesis in the BM and disruption of splenic archicture (Fig. 6 C and D) . The spleen weights were increased (median 540 mg, range 280-1,300 mg). In summary, recipients of bcr͞abl-expressing C͞EBP␣ Ϫ/Ϫ cells develop an infiltrative, transplantable disease with accumulation of immature erythroid cells, fulfilling the Bethesda Criteria of erythroleukemia in mice (10) . The absence of myeloid donor cells in the secondary recipients indicates that the differentiation capacity of the leukemic stem cell is shifted from myeloid to erythroid lineage in the absence of C͞EBP␣.
Expression of Transcription Factors Associated with Erythropoiesis Is
Increased in C͞EBP␣ ؊/؊ Fetal Liver Hematopoietic Cells. To evaluate the mechanism responsible for erythroid lineage commitment in the bcr͞abl-transformed C͞EBP␣ Ϫ/Ϫ cells, expression of genes associated with erythropoiesis was analyzed. Expression of SCL, a transcription factor essential for the commitment to the erythroid lineage (11) , was increased compared with C͞EBP␣ pos cells ( Fig. 2A) . Moreover, GATA-1, which is tightly regulated during erythropoiesis (12) , was up-regulated, along with the precursor marker c-kit (Fig. 2B and data not shown) . This expression pattern might be caused by either an elevated number of erythropoietic progenitors or an altered gene expression profile in precursor cells of the C͞EBP␣ Ϫ/Ϫ fetal livers. Therefore, we analyzed SCL expression in CMPs. This population represents the branching point between the granulocyticmonocytic and the megakaryocytic-erythroid pathway (13) . SCL expression was increased in CMPs of C͞EBP␣ Ϫ/Ϫ fetal livers in comparison with the C͞EBP␣ pos counterpart (Fig. 2C ). In addition, we did not observe an increase in the number of in vitro erythroid colony-forming units derived from C͞EBP␣ Ϫ/Ϫ fetal liver cells compared with wild type (2) . Therefore, in the absence of C͞EBP␣ an alteration in the expression pattern of important erythroid genes was observed. Consistent with these findings, increased expression of GATA-1 was found in infiltrates of mice transplanted with bcr͞abl-expressing C͞EBP␣ Ϫ/Ϫ cells (Fig. 2D) .
Expression of C͞EBP␣ and GATA-1 Is Inversely Correlated in bcr͞abl-
Positive Cells. To further investigate the role of the differential expression of myeloid and erythroid transcription factors in the determination of the cell fate of bcr͞abl-transformed cells, we tested the effect of C͞EBP␣ function on GATA-1 expression in K562 cells. This erythroleukemic cell line is an ideal in vitro surrogate for our mouse model, because it is bcr͞abl-positive and expresses GATA-1. Moreover, there is no endogenous expression of C͞EBP␣ (14) . Myeloid differentiation can be forced by expression of C͞EBP␣ in K562 and other bcr͞abl-positive cell lines (15) . For these experiments, the K562␣ER cell line was used. Upon treatment with ␤-estradiol, the C͞EBP␣-ER fusion protein translocates to the nucleus, allowing C͞EBP␣ to be transcriptionally active. After induction with ␤-estradiol, a decrease in GATA-1 RNA was observed. C͞EBP RNA, a marker of granulocytic differentiation, was increased (Fig. 3A) . Consistently, induction of C͞EBP␣ transcriptional activity led to down-regulation of GATA-1 protein and up-regulation of C͞EBP protein (Fig. 3B) . Therefore, restoration of C͞EBP␣ into a bcr͞abl-expressing line can inhibit erythroid gene expression and induce granulocytic genes.
Id1, a Direct Target of C͞EBP␣, Is Essential for C͞EBP␣-Induced
Myeloid Differentiation. Id1 expression is up-regulated by C͞EBP␣ in CD34 ϩ cells (16) . Because Id1 inhibits erythroid differentiation (17) and enhances neutrophil development (18) , it might play a role for the lineage shift from erythroid to myeloid differentiation upon C͞EBP␣ expression. In K562␣ER cells, Id1 expression was strongly up-regulated as early as 6 h upon induction of C͞EBP␣ (Fig. 3B) . To assess whether Id1 is a direct target gene of C͞EBP␣, chromatin immunoprecipitation (ChIP) was performed. By sequence analysis between mouse and human three homology regions of Ϸ400 bp were defined in the Id1 genomic locus (Fig. 4A) . One of these regions, referred to as 3 prime regulatory element (3PRE), comprises an 8-bp site that was initially described as a pro-B-enhancer in B cells (19) . Binding of C͞EBP proteins to the 3PRE has been described (20) . In induced K562␣ER cells strong binding of C͞EBP␣ to the 3PRE was detected (Fig. 4B) . No binding was detected to the putative C͞EBP binding sites of the two other homology regions (Fig. 4B and data not shown) . Analysis of mouse BM demonstrated binding of C͞EBP␣ to the 3PRE in vivo, indicating that C͞EBP␣-mediated regulation of Id1 expression plays a role in normal myeloid development (Fig. 4C) . To analyze whether Id1 is an essential C͞EBP␣ target for myeloid cell fate, myeloid differentiation was assessed after inhibition of Id1 expression by RNA interference. Using a lentiviral short hairpin RNA against Id1, C͞EBP␣-induced Id1 induction was suppressed (Fig. 4D) . This suppression was accompanied by a markedly impaired C͞EBP induction (Fig. 4D ) and decreased CD11b surface expression (Fig. 4E) . Moreover, glycophorin A surface expression as a marker for erythroid differentiation was maintained despite C͞EBP␣ function (Fig. 4E) . These data corroborate the hypothesis that Id1 is an important target of C͞EBP␣ for myeloid differentiation.
Discussion
Suppression of C͞EBP␣ expression or function is associated with myeloid leukemia in humans (4, 5, 8) . We analyzed the consequences of loss of C͞EBP␣ expression in the context of a murine transplantation model of bcr͞abl-induced myeloproliferative disease. We show that bcr͞abl-expressing C͞EBP␣ Ϫ/Ϫ cells induce an immature, lethal hematologic disease that fulfills the Bethesda Criteria for acute erythroleukemia in mice (10) . Unexpectedly, none of the mice demonstrated an accumulation of myeloblasts. An effect of bcr͞abl itself was unlikely, because erythroid disease occurred only in C͞EBP␣ Ϫ/Ϫ cells, whereas recipients of C͞EBP␣ pos -transduced cells consistently developed a chronic-phase CML-like disease.
Most likely the absence of C͞EBP␣ is responsible for the development of erythroleukemia. C͞EBP␣ Ϫ/Ϫ fetal livers might have more erythroid precursors than wild-type fetal livers. Alternatively, the lack of the C͞EBP␣ gene might alter the differentiation capacity of transformed precursors, leading to a complete block of myeloid differentiation and resulting in preferential erythroid development (Fig. 5) . This hypothesis GATA-1 and Id1 were detected by using nuclear extracts. C͞EBP was detected by using trichloroacetic acid extracts. A rapid and strong up-regulation of Id1 was detected. would be consistent with data showing that C͞EBP␣ expression in CD34 ϩ cells leads to a reduction of erythroid differentiation (16) . Analysis of C͞EBP␣ Ϫ/Ϫ -sorted precursors and experiments with the K562 cell line favor the second hypothesis over the first. Expression of transcription factors essential for erythropoiesis is increased in cells that completely lack C͞EBP␣. C͞EBP␣ is required to direct cell fate from the CMP to GMP stage. Our data show that this central role of C͞EBP␣ for lineage commitment is preserved in malignant hematopoiesis. In the complete absence of C͞EBP␣ the transition from CMP to GMP is blocked and the transformed cells differentiate toward the megakaryocyte͞erythrocyte progenitor (MEP) pathway. Thus, an erythroid phenotype is observed. The observation of an increase in mast cells supports that hypothesis, because both mast cells and MEPs are believed to derive from CMP (21) (Fig. 5) . In summary, our findings show that the isolated deficiency of C͞EBP␣ is not sufficient to confer the differentiation block essential for an AML phenotype. Moreover, our data indicate that Id1 is an important direct target gene of C͞EBP␣ for myeloid lineage commitment.
We hypothesize that a relative reduction of C͞EBP␣ as opposed to its complete absence might be necessary for the development of AML in transformed hematopoietic precursors rather than the erythroleukemia observed in transformed C͞EBP␣ Ϫ/Ϫ fetal liver cells. Analysis of the leukemic stem cell has recently demonstrated the hierarchical system of leukemic stem cell classes (22) , implying that differentiation is a process not only of normal hematopoiesis but also of leukemic cells. In addition, it has been shown that transduction of purified hematopoietic stem cell, CMP, and GMP populations with the MLL-ENL fusion leads to a myeloid leukemia with a phenotype resembling GMP (23) . The same GMP phenotype was detected in a model for myeloid blast crisis induced by expression of bcr͞abl and bcl-2 (24) . Taken together, these findings demonstrate that leukemias with an immature myeloid phenotype, such as AML, or myeloid blast crisis of CML, require a certain level of differentiation capacity. The data in our study indicate that without C͞EBP␣ the cells are not capable of committing to a myeloid cell fate. This finding is consistent with the observations of dominant negative C͞EBP␣ mutations (4) or down-regulation of C͞EBP␣ RNA (5) in human AML patients, either of which would lead to decreased, but not to completely absent, C͞EBP␣ activity. We propose that the remaining C͞EBP␣ activity is not sufficient to sustain normal differentiation, but might be necessary to allow the leukemic cells to differentiate to a GMP phenotype. This hypothesis is consistent with the recent observation that PU.1 hypomorphic mice, which express 20% of wild-type PU.1 levels, develop a lethal AML, whereas conditional and nonconditional PU.1 knockout mice do not (25, 26) . Such residual activity of lineage-determining transcription factors may be necessary for allowing hematopoietic precursors to commit along a differentiation pathway, but not be sufficient for full differentiation (27) . The concept of reduced rather than loss of transcription factor expression might be important for future attempts at modeling leukemia.
Materials and Methods
Retroviral Transduction and Transplantation Assay. The bcr͞abl cDNA (p210) was cloned into a murine stem cell virus retroviral vector plasmid containing an internal ribosome entry site (IRES)-GFP cassette (28) . For generation of virus, Bosc 23 cells were transfected with the retroviral vector and a plasmid expressing ecotropic env and gag polymerase by Lipofectamine reagent (GIBCO͞BRL) (29) . C͞EBP␣ ϩ͞Ϫ mice were crossed at least five breeding cycles into the C57BL͞6 background. Fetal livers were harvested at days 14.5-16.5 of gestation. Genotype was determined by touch smears and confirmed by Southern blot analysis (30) . Fetal liver cells were placed on fibronectin-coated plates (Sigma) with bcr͞abl IRES-GFP virus, 4 ng͞ml of polybrene (Sigma), 10 ng͞ml of IL-3 (R & D Systems), and 10 ng͞ml of stem cell factor (R & D Systems). Two spinoculations were done, and 0.25 million to 1 million cells were injected into the tail vein of sublethally irradiated (850 rad) congeneic recipients. Secondary recipients were irradiated with 500 rad, and 5 million cells were injected.
Cell Culture and Lentiviral Transduction. K562␣ER cells were maintained in RPMI medium 1640 supplemented with 10% charcoalstripped FCS at 37°C and 5% CO 2 (14) . Short hairpin RNA against Id1 (target sequence: AAGGTGAGCAAGGTG-GAGATT) was cloned into a lentiviral construct, virus was prepared, and cells were transduced as described (31) . siGL2 was used as a control short hairpin RNA.
Western Blot Analysis. Whole-cell lysates were obtained either by radioimmunoprecipitation assay or trichloroacetic acid extraction (32) . Nuclear extracts were performed according to Andrews and Faller (33) . Proteins were separated on a 10% polyacrylamide gel, transferred to a nitrocellulose membrane, and incubated with a 1:1,000 dilution of an antibody for c-abl or C͞EBP, a 1:500 dilution for Id1, or a 1:250 dilution of an antibody against GATA-1 (all Santa Cruz Biotechnology). An antibody against ␤-actin (Sigma) or Sp1 (Upstate, Charlottesville, VA) was used as control for loading and protein integrity for whole-cell lysates and nuclear extracts, respectively.
Flow Cytometry. After lysis of erythrocytes BM and spleen cells were labeled with biotin-, phycoerythrin (PE)-, or allophycocyanin (APC)-conjugated antibodies against the following molecules: c-kit (2B8), Gr-1 (RB6-8C5), B220 (RA3-6B2), CD3 (17A2), TER-119, CD71 (Pharmingen) or Mac-1͞CD11b (M1͞ 70.15) (Caltag, Burlingame, CA) followed by incubation with APC-conjugated streptavidin if necessary. K562 cells were labeled with a PE-conjugated antibody against glycophorin A or CD11b (Becton Dickinson). Dead cells were excluded by propidium iodide staining. Cells were analyzed on a Cytomics FC500 (Beckman Coulter) or a FACScalibur (Becton Dickinson). For analysis of SCL expression in purified progenitors, the CMP population defined as lin Ϫ , Sca1
Ϫ , c-kit ϩ , CD34 ϩ , and Fc␥RIII͞II low was sorted by using a double laser (488-nm͞ 350-nm Enterprise II ϩ 647-nm Spectrum) high-speed cell sorter (Moflo-MLS; Cytomation, Fort Collins, CO) (13).
Hematology and Histology. Blood counts were performed on a Hemavet Analyzer (CDC Technologies, Oxford, CT). Differential counts were done manually on 300 nucleated blood cells per (6, 35) . (Left) In the presence of C͞EBP␣, the majority of cells differentiate toward the granulocytic lineage, derived from the GMP. (Right) C͞EBP␣ deficiency leads to a block from the CMP to the GMP stage and thus, the myeloproliferative effect of bcr͞abl results in a predominance of early erythroid cells and mast cells. Our data show that C͞EBP␣ retains its essential role for myeloid cell fate decision in malignant hematopoiesis. MEP, megakaryocyte͞erythrocyte progenitor; McP, presumptive mast cell precursor.
